Measuring Clinical Benefit: Use of Patient-Reported Outcomes (PRO) in Primary Brain Tumor Clinical Trials

被引：0
|
作者：
Terri S. Armstrong
机构：
[1] UTHSC-SON,Department of Family Health
[2] MDACC,Department of Neuro
来源：
Current Oncology Reports | 2013年 / 15卷
关键词：
Brain tumor; Quality of life; Symptoms; Patient-reported outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Primary brain tumors and their treatment are associated with a significant impact on function and quality of life (QOL). Patient-reported outcomes (PROs) are measures that allow report of the impact directly from the patient. Instruments to measure both QOL and symptom burden have been developed for use in the primary brain tumor patient population. Use of these instruments coupled with tumor response assessment and other objective measures will allow for evaluation of the net clinical benefit for the patient.
引用
收藏
页码：27 / 32
页数：5
相关论文
共 50 条
  • [1] Measuring Clinical Benefit: Use of Patient-Reported Outcomes (PRO) in Primary Brain Tumor Clinical Trials
    Armstrong, Terri S.
    CURRENT ONCOLOGY REPORTS, 2013, 15 (01) : 27 - 32
  • [2] Measuring patient-reported outcomes: moving from clinical trials into clinical practice
    Valderas, Jose M.
    Alonso, Jordi
    Guyatt, Gordon H.
    MEDICAL JOURNAL OF AUSTRALIA, 2008, 189 (02) : 93 - 94
  • [3] Patient-Reported Outcomes and Clinical Trials
    Althof, Stanley E.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (07): : 1027 - 1028
  • [4] Patient-reported outcomes in asthma clinical trials
    Braido, Fulvio
    Baiardini, Ilaria
    Canonica, Giorgio W.
    CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (01) : 70 - 77
  • [5] PATIENT-REPORTED OUTCOMES IN RANDOMIZED CLINICAL TRIALS
    Shoulson, I.
    MUSCLE & NERVE, 2014, 50 : S2 - S2
  • [6] Patient Reported Endpoints for Measuring Clinical Benefit in (High Grade Glioma) Primary Brain Tumor Patients
    Armstrong, Terri S.
    Gilbert, Mark R.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 519 - 528
  • [7] Patient Reported Endpoints for Measuring Clinical Benefit in (High Grade Glioma) Primary Brain Tumor Patients
    Terri S. Armstrong
    Mark R. Gilbert
    Current Treatment Options in Oncology, 2014, 15 : 519 - 528
  • [8] The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials
    Snyder, Claire
    Crossnohere, Norah
    King, Madeleine
    Reeve, Bryce B.
    Bottomley, Andrew
    Calvert, Melanie
    Thorner, Elissa
    Wu, Albert W.
    Brundage, Michael
    CLINICAL TRIALS, 2022, 19 (03) : 277 - 284
  • [9] Patient-reported outcomes in lupus clinical trials with biologics
    Annapureddy, N.
    Devilliers, H.
    Jolly, M.
    LUPUS, 2016, 25 (10) : 1111 - 1121
  • [10] Patient-Reported Outcomes Clinical Trials in Ovarian Cancer
    Carey, Mark S.
    Gotay, Carolyn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 782 - 787
12345